Gene · 92
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics network analyses of growth differentiation factor 11. | Open Life Sci | 2022 | 35582621 | PubTator, text mining | PubMed |
| Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival. | Genome Med | 2022 | 35581624 | PubTator, text mining | PubMed |
| Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant. | Thorax | 2022 | 35580897 | PubTator, text mining | PubMed |
| Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts. | Int J Cancer | 2022 | 35567574 | PubTator, text mining | PubMed |
| Clinical Developmental Cardiology for Understanding Etiology of Congenital Heart Disease. | J Clin Med | 2022 | 35566507 | PubTator, text mining | PubMed |
| Development of six immune-related lncRNA signature prognostic model for smoking-positive lung adenocarcinoma. | J Clin Lab Anal | 2022 | 35561270 | PubTator, text mining | PubMed |
| The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications. | Front Immunol | 2022 | 35558080 | PubTator, text mining | PubMed |
| Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial. | Circ Genom Precis Med | 2022 | 35543701 | PubTator, text mining | PubMed |
| Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma. | Int J Genomics | 2022 | 35535346 | PubTator, text mining | PubMed |
| An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy. | Biol Direct | 2022 | 35534873 | PubTator, text mining | PubMed |
| Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1. | J Clin Invest | 2022 | 35511419 | PubTator, text mining | PubMed |
| Mapping the epithelial-immune cell interactome upon infection in the gut and the upper airways. | NPJ Syst Biol Appl | 2022 | 35501398 | PubTator, text mining | PubMed |
| RNA sequence analysis identified bone morphogenetic protein-2 (BMP2) as a biomarker underlying form deprivation myopia. | Biochem Biophys Rep | 2022 | 35494490 | PubTator, text mining | PubMed |
| Comprehensive profiling of 1015 patients' exomes reveals genomic-clinical associations in colorectal cancer. | Nat Commun | 2022 | 35487942 | PubTator, text mining | PubMed |
| Identifying preeclampsia-associated genes using a control theory method. | Brief Funct Genomics | 2022 | 35484822 | PubTator, text mining | PubMed |
| Molecular pathogenesis and systemic therapies for hepatocellular carcinoma. | Nat Cancer | 2022 | 35484418 | PubTator, text mining | PubMed |
| A minority of somatically mutated genes in pre-existing fatty liver disease have prognostic importance in the development of NAFLD. | Liver Int | 2022 | 35474605 | PubTator, text mining | PubMed |
| Vascular Calcification: New Insights Into BMP Type I Receptor A. | Front Pharmacol | 2022 | 35462911 | PubTator, text mining | PubMed |
| Liquid Biopsy as a Source of Nucleic Acid Biomarkers in the Diagnosis and Management of Lynch Syndrome. | Int J Mol Sci | 2022 | 35457101 | PubTator, text mining | PubMed |
| Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts. | Int J Mol Sci | 2022 | 35456903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92/papers?page=19